chartexchange

KLRS
Kalaris Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:49:01 PM EST
1.34USD-2.190%(-0.03)14,635
1.1700Bid1.3500Ask0.1800Spread

KLRS Financials

In Q3 FY 2026 (ended ), Kalaris Therapeutics, Inc. Common Stock (KLRS) reported net income of −$11.03M, operating cash flow of −$10.56M, and assets of $89M (filed ).

Loading financial flows…